MedPath

A comparative study of 2% lignocaine nebulization with 0.5% ropivacaine nebulization for controlling blood pressure and heart rate during intubation and extubation after general anaesthesia

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/09/045630
Lead Sponsor
Goa Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade I and II patients

Exclusion Criteria

1.Patient Refusal

2.Obstetric patients

3.Known allergy to drugs involved in the study

4.Patients with clinical evidence of difficult airway

5.Emergency surgical procedures with full stomach requiring RSI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of 2% lignocaine with 0.5% ropivacaine 5ml nebulization ,in attenuation of haemodynamic responses during endotracheal intubation and extubationTimepoint: At Baseline <br/ ><br>Before Laryngoscopy and intubation <br/ ><br>Immediately after Laryngoscopy and intubation <br/ ><br>Every 1 minute for next 5 minutes <br/ ><br>10 minutes after intubation <br/ ><br>Upon anaesthetic withdrawal <br/ ><br> Upon eye opening on verbal command <br/ ><br>Upon tracheal extubation <br/ ><br>Two minutes after extubation <br/ ><br> <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To evaluate cough response and haemodynamics during extubation with airway topicalizationTimepoint: severity of cough and haemodynamic parameters at the time of extubation are studied
© Copyright 2025. All Rights Reserved by MedPath